오가논 & Co (OGN)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 배당 이력

Relative Volume:

오가논 & Co Stock (OGN) Company Profile

Healthcare (1091)

551-430-6000

30 HUDSON STREET, JERSEY CITY

최신 SEC 제출 서류

OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
OGN Organon Co	13.53	3.54B	6.16B	246.00M	708.00M	0.9387
LLY Lilly Eli Co	1,160.71	1.02T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	249.28	598.96B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	255.32	447.67B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	125.52	307.25B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	154.34	285.37B	54.66B	13.58B	16.05B	7.0171

오가논 & Co Stock (OGN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-12-09	개시	Barclays	Underweight
2025-10-27	다운그레이드	Piper Sandler	Overweight → Underweight
2025-05-02	다운그레이드	Evercore ISI	Outperform → In-line
2024-09-06	다운그레이드	JP Morgan	Neutral → Underweight
2023-11-03	다운그레이드	Goldman	Buy → Neutral
2023-09-21	개시	Barclays	Overweight
2023-03-16	개시	Raymond James	Outperform
2022-10-14	다운그레이드	BofA Securities	Neutral → Underperform
2022-09-06	업그레이드	Piper Sandler	Neutral → Overweight
2022-08-05	다운그레이드	BofA Securities	Buy → Neutral
2022-04-27	개시	Goldman	Buy
2022-04-06	재개	Morgan Stanley	Equal-Weight
2021-10-07	개시	Piper Sandler	Neutral
2021-09-01	개시	BofA Securities	Buy
2021-07-22	개시	Citigroup	Buy
2021-06-15	개시	JP Morgan	Neutral
2021-06-11	개시	Morgan Stanley	Equal-Weight
2021-06-10	개시	Evercore ISI	Outperform

오가논 & Co 주식(OGN)의 최신 뉴스

오가논 & Co (OGN) 재무 분석

오가논 & Co (OGN)

오가논 & Co Stock (OGN) Company Profile

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

오가논 & Co Stock (OGN) Upgrades & Downgrades

오가논 & Co 주식(OGN)의 최신 뉴스

Organon & Co. (OGN) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Price-Driven Insight from (OGN) for Rule-Based Strategy - Stock Traders Daily

Organon stock trades steady as women’s health focus meets mixed earnings momentum - Ad-hoc-news.de

XS233225070 Bond Profile — Key Metrics - TradingView

[8-K] Organon & Co. Reports Material Event - Stock Titan

Samsung Bioepis and Organon expand biosimilar commercialisation agreement in Australia - BioSpectrum Asia

OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits

Organon to report Q2 2026 results, suspends earnings calls - scanx.trade

Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing - Business Wire

Samsung Bioepis and Organon broaden biosimilar access in Australia - The Pharma Letter

What Sparked Organon's Recent Stock Surge - Kavout | AI

Samsung Bioepis, Organon expand biosimilar partnership in Australia - koreabiomed.com

Samsung Bioepis and Organon Broaden Biosimilar Access in Australia - Businesskorea

MRK5808585 Bond Profile — Key Metrics - TradingView

Organon & Co. (OGN) is a trending stock: Facts to know before betting on it - MSN

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Organon & Co.: Great Odds, Small Prize, Big Penalty (NYSE:OGN) - Seeking Alpha

Sun Pharma to Acquire Organon in US$11.75 Billion Deal, Strengthening Global Healthcare Portfolio - eHealth Magazine

Organon (OGN) Q1 2026 earnings summary - Quartr

Organon & Co. (OGN) Holds Steady Above $13.50 After Modest UptickJelly Roll Trade - DonanımHaber

Organon (OGN) Proxy filing Summary - Quartr

SBI Joins 10 Global Lenders in Sun Pharma's Organon Financing Deal - outlookbusiness.com

SBI joins global banks to fund Sun's Organon buy - Magzter

Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada - AOL.com

SBI joins global banks to fund Sun Pharma's $11.75 billion Organon buy - Business Standard

Organon to present VTAMA cream data at pediatric dermatology meeting - Investing.com

Organon to present VTAMA cream data at pediatric dermatology meeting By Investing.com - Investing.com Nigeria

Organon’s VTAMA data heads to pediatric dermatology meeting - Stock Titan

Sun Pharma's $11.8 bn Organon buy drives India's M&A value to 4-year high - Business Standard

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance

OGNOrganon & Co Volatility & Greeks - Finviz

OGN Q1 2026 Earnings: EPS Misses Estimates Amidst Operational ChallengesShare Repurchase Impact - dars.gov.et

Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets? - Insider Monkey

Organon & Co. Actuals & Estimates (NYSE:OGN) - TradingView

Organon & Co updates strategic focus, shares watched on NYSE - AD HOC NEWS

Organon wins FDA nod to expand TOFIDENCE use in severe CRS & COVID-19 - MSN

Class Action Lawsuit Filed: Organon & Co. (OGN)Join by July 22, 2025Contact Levi & Korsinsky - The National Law Review

Enterprise value to EBITDA forward of Organon & Co. – MUN:7XP - TradingView

Price to earnings forward of Organon & Co. – NYSE:OGN - TradingView

Price to earnings forward of Organon & Co. – LSE:0A9W - TradingView

Organon and Henlius launch Prolia and Xgeva biosimilars in Canada - MSN

Mayne Pharma appoints former Organon & Co executive Meghan Rivera to board - MSN

(OGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Price to sales forward of Organon & Co. – NYSE:OGN - TradingView

Enterprise value to EBITDA forward of Organon & Co. – LSE:0A9W - TradingView

Enterprise value to revenue forward of Organon & Co. – NYSE:OGN - TradingView

Shareholders of Organon & Co. (OGN): Protect Your Rights Before July 22, 2025Contact Levi & Korsinsky - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Stockholders to Connect - The National Law Review

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Organon & Co. (OGN) Investors of July 22, 2025 Deadline - The National Law Review

Levi & Korsinsky Notifies Organon & Co. (OGN) InvestorsLead Plaintiff Deadline on July 22, 2025 - The National Law Review

OGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review

오가논 & Co (OGN) 재무 분석

매출

순이익

현금흐름

주당 순 이익

OGN과 유사한 종목